We are live on
!
Find out more
JCG
JHL Capital Group Portfolio holdings
AUM
$805M
1-Year Est. Return
50.84%
This Fund
S&P 500
This Quarter
Est. Return
+5.23%
1 Year Est. Return
-50.84%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.29B
AUM Growth
-$235M
(-15%)
Cap. Flow
-$294M
Cap. Flow
% of AUM
-22.77%
Top 10 Holdings %
Top 10 Hldgs %
96.85%
Holding
24
New
8
Increased
2
Reduced
5
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$18.5M |
| 2 |
Ally Financial
ALLY
|
+$13.5M |
| 3 |
Coherus Oncology
CHRS
|
+$7M |
| 4 |
SK Telecom
SKM
|
+$3.78M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$1.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$138M |
| 2 |
AT&T
T
|
+$69M |
| 3 |
PRXL
Parexel International Corp
PRXL
|
+$32.6M |
| 4 |
Verizon
VZ
|
+$31.2M |
| 5 |
HRG
HRG Group, Inc.
HRG
|
+$11.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 11.29% |
| 2 | Industrials | 5.17% |
| 3 | Technology | 3.16% |
| 4 | Financials | 1.03% |
| 5 | Healthcare | 0.64% |
Similar funds
QA
HT
BFG
IMOV
DW
KI
SG
OAMG
JHL Capital Group's Q4 2016 Portfolio in Review
As of Q4 2016, JHL Capital Group held 24 positions worth $1.29B, down 15% from $1.52B the previous quarter. Its ten largest holdings account for 97% of the portfolio.
JHL Capital Group withdrew a net $294M in Q4 2016, closing 9 positions and reducing 5 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $138M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 11% of assets, down from 15% a quarter earlier, followed by Industrials and Technology.
Against the trend, JHL Capital Group opened a new position in Ally Financial worth $13.3M.
- JHL Capital Group's largest Q4 2016 buy was Ally Financial: 700,000 shares worth $13.3M.
- JHL Capital Group added most to Qualcomm in Q4 2016, an estimated $18.5M increase.
- JHL Capital Group's biggest Q4 2016 reduction was HRG Group, Inc., cutting an estimated $11.5M.
- JHL Capital Group fully exited IVERIC bio, Inc. Common Stock in Q4 2016, selling an estimated $138M.
- JHL Capital Group's ten largest holdings make up 97% of its $1.29B portfolio in Q4 2016.
- JHL Capital Group opened 8 new positions and closed 9 in Q4 2016.
- JHL Capital Group's portfolio value fell 15% quarter-over-quarter to $1.29B.
Based on JHL Capital Group's 13F filing for Q4 2016, filed 14 Feb 2017.